Bradesco New President: Replacement Of Luiz Carlos Trabuco

Bradesco Seguros, a world-recognized bank which came to a point and announced its new president. The man elected was Octavio de Lazari who was to replace the successful man in the executive Luiz Carlos Trabuco. Even though, Trabuco was to remain as the president until an ordinary meeting was held before Octavio could take over.

Lazari who was 54 years was the name that had been quoted so that he can succeed Luiz Carlos Trabuco. Lazari started working when he was 15 years as branch agent in the street which is popular in Sao Paulo. He was a gifted footballer but abandoned that dream so that he can work for the bank where his father was the client. His father had used the manager’s relationship so that he could claim a vacancy for his son.

The succession process started in October which is the largest second private bank. The bank had said that a new president should come from financial institution staff. Lazaro had resigned from being the chairman of Board of Directors in the bank. By then Luiz Carlos Trabuco had ascended from the collegiate presidency.

Bradesco had pointed out personal merits using the material fact of Lazari. The organization had recognized and included in the companions where he deserved the distinction of all of them and helped to maintain continuity line and was a fundamental key that ensured prominent positions that the bank has been holding in international and national financial scenarios.

Read more: Próximo presidente do Bradesco sairá da diretoria do banco, diz Trabuco

Lazari went to Osasco and attained from a faculty of Administrative and Economic Sciences, a degree in Economics where his specialization area is marketing and financial strategies where he attained from FIA. He is the successful man to remain as the president of Bradesco Seguros.

In the closer of 2017, Bradesco Seguros announced to have closed with R $ 76.3 billion which was an increase of 6.8% from what it had achieved when it had closed in 2016. due to the good result, the company was able to achieve market share that was higher than previous years of 26%.

The bankers had become optimistic because of the performance of the national economy of 2018. There was citing inflation to be able to remain in the middle of the target, where there will be basic low-interest rate, and the GDP will be growing in between 2% and 3% according to istoedinheiro.com.br. in addition, the employment will not be increasing so that the nation can have better years than it ever had before. Despite the optimism, Trabuco and Lazari had stressed the importance to have the pension reform.

Luiz Carlos Trabuco leaving the management of Bradesco as CEO had a delay because of the age extension limit exercise which increased from 65 to 67 years that was in integration with the HSBC. Even though, the substitute Lazari Brandao, who was to become the successor was anticipated after he resigned from the company. This was because the executive could remain as the president of the institution up to 2019. this was an attempt that the company didn’t comment about.

Learn more about Luiz Carlos Trabuco: https://oglobo.globo.com/economia/bradesco-anuncia-novo-presidente-octavio-de-lazari-junior-vai-substituir-luiz-carlos-trabuco-cappi-22365414#ixzz56wDld69g

Tempus Co-Founder Eric Lefkofsky At Head of Paradigm Shift in Medical Field.

Chicago has always been a hotbed for technological innovation and now the Windy City is getting involved with the medical field through a rising start-up known as Tempus. Tempus was co-founded by Eric Lefkofsky in 2015 with the goal of helping to revolutionize the way that customers and medical health professionals interact with and access important medical data. The company is now valued at north of $1 billion and this has allowed Tempus to earn the coveted Unicorn Status.

The goal of Tempus is to utilize data in a way that helps to streamline and maximize the effectiveness of cancer care in the modern medical world. Having seen how the system works up close, through a personal relationship, Lefkofsky came to the realization that there is a ton of room for improvement within the field. So, Tempus compiles data from multiple sources before porting it into an accessible database. This database is then utilized by patients, family members and healthcare professionals in order to track cancer care approaches and see which ones are most effective.

We are currently living in the data-driven age of technology and Lefkofsky’s approach as the co-founder of Tempus is serving as a unique opportunity to help change lives through data. Leaning on clinical data and molecular data, Tempus is quickly becoming vital in the search for trends among cancer care patients. Tempus relies not only on old data but it also ports data from patients that are currently undergoing treatment. The data collection system is advanced enough that it can utilize digital database and simple enough that it can be used to port in handwritten doctor notes into a searchable platform.

Right now, Tempus employs nearly 400 workers and their business forecast shows that the company will be adding nearly 30 new employees every single month from here on out. With success in their approach, Tempus has quickly captured the eye of several major investors. It was recently announced that Tempus had earned an additional $80 million in investments which pushes their 3-year-total to just north of $210 million. With this kind of early success, the sky appears to be the limit for Tempus.

Eric Lefkofsky

Drew Madden Proven Healthcare Exec and Entrepreneur Advises On CVS and Amazon

Amazon Enters Pharmacy Business

In light of the fact that Amazon is entering the pharmacy business, CVS is considering an acquisition of Aetna. Because Amazon owns Whole Foods, the potential competition for CVS could be very intense. CVS is seeing the acquisition of Aetna as being a play to ward off competition in the healthcare business. Both Amazon and CVS want to own the experience that patients have, so owning the consumer’s experience is a huge competitive advantage that CVS would have.

Health Care in US a $3 Trillion Industry

In the U.S., health care is a $3 Trillion industry with the U.S. spending more per capita than any other country. Unfortunately, many entrepreneurs aren’t willing to start healthcare and health tech companies. The reason why so many entrepreneurs are afraid of healthcare is because of regulation and incentives that don’t necessarily favor entrepreneurs.

President Obama Hires CTO To Change Culture of Healthcare

President Obama hired a CTO whom helped to change the culture of the healthcare industry. The CTO created new innovation initiatives to promote entrepreneurship, such as an online challenge creation system for inviting private sector innovators to solve problems.

Opportunities Abound To Solve Problems For Health Industry

There are also plenty of other opportunities to solve issues that are creating problems for the healthcare industry. Everything from end of life care to medication management has potential for disruption. There are also challenges with insurance reimbursement and logistics that serve as hurdles to the efficient delivery of healthcare.

Drew Madden Experienced Health Care Leader and Executive

Drew Madden is a proven healthcare executive with experience in IT. His background includes time spent at some of the largest health IT companies in the world. His career began at Cerner corporation, a company which produces an EHR platform. This was followed by Ingenix, a subsidiary of United Health Care. Finally, he spent 5 years at Nordic Consulting Partners, a company that he grew from 10 to 725 employees.

Jeunesse Global’s Reserve helps prevent heart disease and increase lifespan

For decades, scientists and medical professionals have known that there is a positive link between the consumption of wine and an overall decrease in cardiovascular disease. So strong is this relationship that people who regularly drink wine in moderation may have increased life expectancies of up to 5 years longer than those who do not.

Yet, despite this strong and highly compelling evidence of beneficial effects, the major medical bodies still do not recommend that those who do not currently drink wine begin doing so. While this may seem like a surprising contradiction, it stems from the dangers of alcohol consumption itself. Even though only 10 to 15 percent of all people who begin to drink alcohol will go on to develop an alcohol use disorder, the consequences of becoming an alcoholic are so severe that the benefits of wine consumption, even as notable as they are, get cancelled out at the population level by the risk of people developing alcohol use disorders.

Still, many researchers, companies and medical organizations have attempted to find a way to achieve the same benefits of moderate wine consumption without incurring any of the risks associated with the consumption of alcohol.

Now, Jeunesse Global, one of the most innovative health and beauty companies in the world, has devised a product that is able to confer all of the benefits of wine consumption and even more. Additionally, their solution contains no alcohol. Called Reserve, the drink contains resveratrol, one of the most potent health-protective ingredients in wine. Reserve also contains a number of so-called superfruits, including pomegranate, blueberry, acai, and concord grape. Together, these things make Reserve one of the most health-promoting and great-tasting health drinks on the market.

With so many antioxidants, Reserve packs the health-protecting punch of daily wine consumption with none of the risks. In addition to protecting against heart disease, Reserve also protects against diseases like peripheral artery disease, stroke and kidney dysfunction. It has been clinically shown to reduce the oxidative stress caused by free radicals. This makes Reserve a proven means to prevent against some of the worst ailments associated with aging.

https://www.facebook.com/JeunesseHQ/